Rapporto sull’analisi delle dimensioni del mercato e delle quote del mercato Diagnostica del cancro al seno | Previsioni 2031

  • Report Code : TIPRE00003015
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Breast Cancer Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

Il cancro al seno è la crescita incontrollabile delle cellule tumorali nel seno. Generalmente, il cancro si forma nei lobuli o nei dotti del seno. Esistono due tipi di cancro al seno, cancro al seno invasivo e cancro al seno non invasivo. Negli ultimi anni si è registrato un aumento dei casi di cancro al seno nelle donne. Recentemente, il cancro al seno viene rilevato anche negli uomini. L’American Cancer Society ha stimato che nel 2015 sarebbero stati diagnosticati più di 2.000 uomini e più di 400 uomini sarebbero morti a causa della malattia. Si prevede che la crescente prevalenza del cancro al seno e la tecnologia avanzata per la sua diagnosi alimenteranno la crescita del mercato della diagnosi del cancro al seno durante il periodo di previsione. Inoltre, si prevede che l’introduzione di prodotti nuovi e migliori da parte dei produttori offrirà opportunità di crescita alle aziende sul mercato. L'analisi del mercato globale della diagnosi del cancro al seno fino al 2031 è uno studio specializzato e approfondito del settore IT sanitario con particolare attenzione all'andamento del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato globale con una segmentazione dettagliata del mercato per tipo di screening, tecnologia e area geografica. Si prevede che il mercato globale assisterà a una crescita elevata durante il periodo di previsione. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato Diagnosi del cancro al seno e offre tendenze e opportunità chiave nel mercato. Il mercato globale della diagnosi del cancro al seno è segmentato in base al tipo e alla tecnologia di screening. In base al tipo di screening, il mercato è segmentato in test di laboratorio, biopsia, imaging e altri tipi di screening. Sulla base della tecnologia, il mercato della diagnosi del cancro al seno è classificato come ibridazione fluorescente in situ (FISH), ibridazione genomica comparativa (CGH), immunoistochimica (IHC) e altre tecnologie. Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale della diagnosi del cancro al seno in base al tipo e alla tecnologia di screening. Fornisce inoltre le dimensioni del mercato e le previsioni fino al 2031 per il mercato complessivo rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e America meridionale e centrale. Il mercato della diagnosi del cancro al seno in ciascuna regione viene successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l’analisi e le previsioni di 13 contee a livello globale insieme alle tendenze attuali e alle opportunità prevalenti nella regione. Si prevede che il Nord America contribuirà alla quota maggiore del mercato della diagnosi del cancro al seno nei prossimi anni, a causa della crescente prevalenza di casi di cancro al seno nella regione negli ultimi anni. Si prevede che l’Asia del Pacifico assisterà a una crescita significativa del mercato durante il periodo di previsione, a causa dei crescenti investimenti di operatori stranieri nelle economie in via di sviluppo come Cina e India. Il rapporto analizza i fattori che influenzano il mercato della diagnosi del cancro al seno sia dal lato della domanda che dell’offerta e valuta ulteriormente le dinamiche di mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e America meridionale e centrale dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato della diagnosi del cancro al seno in queste regioni. Il rapporto include anche i profili delle principali società di diagnosi del cancro al seno insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni e sviluppi chiave negli ultimi cinque anni. Alcuni dei principali attori che operano nel mercato della diagnosi del cancro al seno includono, Abbott, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GENERAL ELECTRIC COMPANY, Hologic, Inc., Koninklijke Philips NV, Micrima Limited, Provista Diagnostics, Inc., Siemens Healthcare GmbH e Thermo Fisher Scientific Inc. tra gli altri.

Breast Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo di screening
  • test di laboratorio
  • biopsia
  • imaging e altri tipi di screening
By Tecnologia
  • ibridazione fluorescente in situ
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Abbott
  • F Hoffmann La Roche Ltd
  • Fujifilm Holdings Corporation
  • GENERAL ELECTRIC COMPANY
  • Hologic Inc
  • Koninklijke Philips N V
  • Micrima Limited
  • Provista Diagnostics Inc
  • Siemens Healthcare GmbH
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. Fujifilm Holdings Corporation
    4. GENERAL ELECTRIC COMPANY
    5. Hologic, Inc.
    6. Koninklijke Philips N.V.
    7. Micrima Limited
    8. Provista Diagnostics, Inc.
    9. Siemens Healthcare GmbH
    10. Thermo Fisher Scientific Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Medical Device : READ MORE..